Evidence map›Paper›PMID 40191395›Full record

ArticleImaging science in dentistry2025

Basal cell adenocarcinoma in the retromolar trigone: A case report.

Bong-Hae Cho, Yun-Hoa Jung, Jae-Joon Hwang, Mi-Heon Ryu, Ji-Soo Lee

Abstract readCase Reports
In one paragraph

Article in Imaging science in dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bong-Hae ChoDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0000-0002-8292-6119
Yun-Hoa JungDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0000-0003-4431-6763
Jae-Joon HwangDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0000-0003-0379-8460
Mi-Heon RyuDepartment of Oral Pathology, School of Dentistry, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0000-0003-1283-9762
Ji-Soo LeeDepartment of Oral and Maxillofacial Radiology, School of Dentistry, Pusan National University, Yangsan, Korea.ORCID https://orcid.org/0009-0000-5210-1696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basal cell adenocarcinoma, considered to be the malignant counterpart of basal cell adenoma, is a rare, low-grade malignant tumor of the salivary glands, accounting for 1-2% of salivary gland malignancies. It predominantly affects the parotid gland, while involvement of the minor salivary glands is exceptionally rare. This report presented a case of basal cell adenocarcinoma involving the left retromolar trigone in a 54-year-old woman. The initial provisional diagnosis suggested a benign or low-grade malignant salivary tumor. Advanced magnetic resonance imaging techniques, including diffusion-weighted imaging and apparent diffusion coefficient analysis, aided in the preoperative prediction of malignancy, and an incisional biopsy confirmed the diagnosis of basal cell adenocarcinoma. This case underscored the challenge of distinguishing basal cell adenocarcinoma from benign salivary tumors, as clinical and imaging features often overlap. Surgical excision remains the primary treatment, yielding favorable outcomes; however, long-term follow-up is crucial due to the risk of recurrence.

Indexed as

Adenocarcinoma, Basal CellMagnetic Resonance ImagingSalivary Gland, Minor

Identifiers

PMID40191395
PMCPMC11966018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.